Associated Papers
Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout.
Vávra J et al.
Disease Markers, 2024
Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation.
Zhang T et al.
Peerj, 2024
39465171 (PubMed )
Supplement: peerj-12-18360-s002.7z › drug-metabolizing_enzymes_and_transporter__DMET__microarray › markerlist.xlsx › markerlist.TXT
The substrate and inhibitor binding mechanism of polyspecific transporter OAT1 revealed by high-resolution cryo-EM.
Dou T et al.
Nature Structural & Molecular Biology, 2023
Identification of genetic polymorphisms of human OAT1 and OAT2 genes and their relationship to hOAT2 expression in human liver.
Shin HJ et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2010
Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy.
Ieiri I et al.
Expert Opinion on Drug Metabolism & Toxicology, 2006
Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues in Clinical Neuroscience, 2006
Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1).
Fujita T et al.
Pharmacogenetics and Genomics, 2005
Select a paper to view details